These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 15288958)
1. Inactivation of HSV-2 by ascorbate-Cu(II) and its protecting evaluation in CF-1 mice against encephalitis. Betanzos-Cabrera G; Ramírez FJ; Muñoz JL; Barrón BL; Maldonado R J Virol Methods; 2004 Sep; 120(2):161-5. PubMed ID: 15288958 [TBL] [Abstract][Full Text] [Related]
2. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge. Evans IA; Jones CA J Infect Dis; 2002 Jun; 185(11):1550-60. PubMed ID: 12023760 [TBL] [Abstract][Full Text] [Related]
4. [Investigation of herpes simplex virus in viral meningoencephalitis suspected cases using molecular and serological methods]. Akçali A; Ozkaya E; Yilmaz D; Uyar Y; Oncül O Mikrobiyol Bul; 2008 Jul; 42(3):421-8. PubMed ID: 18822885 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice. Carlucci MJ; Scolaro LA; Noseda MD; Cerezo AS; Damonte EB Antiviral Res; 2004 Nov; 64(2):137-41. PubMed ID: 15498610 [TBL] [Abstract][Full Text] [Related]
6. Euphorbia thymifolia suppresses herpes simplex virus-2 infection by directly inactivating virus infectivity. Yang CM; Cheng HY; Lin TC; Chiang LC; Lin CC Clin Exp Pharmacol Physiol; 2005; 32(5-6):346-9. PubMed ID: 15854140 [TBL] [Abstract][Full Text] [Related]
7. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice. Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2. Tomé JP; Neves MG; Tomé AC; Cavaleiro JA; Mendonça AF; Pegado IN; Duarte R; Valdeira ML Bioorg Med Chem; 2005 Jun; 13(12):3878-88. PubMed ID: 15911304 [TBL] [Abstract][Full Text] [Related]
10. [Protective effects of trichosanthin in Herpes simplex virus-1 encephalitis in mice]. Chen GF; Huang WG; Chen FY; Shan JL Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):239-41. PubMed ID: 16787600 [TBL] [Abstract][Full Text] [Related]
11. Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2. Quenelle DC; Collins DJ; Marciani DJ; Kern ER Vaccine; 2006 Mar; 24(10):1515-22. PubMed ID: 16288820 [TBL] [Abstract][Full Text] [Related]
12. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice. Tengvall S; Harandi AM J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349 [TBL] [Abstract][Full Text] [Related]
13. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice. Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902 [TBL] [Abstract][Full Text] [Related]
14. Neurological complications of herpes simplex virus type 2 infection. Berger JR; Houff S Arch Neurol; 2008 May; 65(5):596-600. PubMed ID: 18474734 [TBL] [Abstract][Full Text] [Related]
15. Effects of electrolytes on virus inactivation by acidic solutions. Nishide M; Tsujimoto K; Uozaki M; Ikeda K; Yamasaki H; Koyama AH; Arakawa T Int J Mol Med; 2011 Jun; 27(6):803-9. PubMed ID: 21468540 [TBL] [Abstract][Full Text] [Related]
16. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2. Kwant A; Rosenthal KL Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the chromosome-damaging action of ascorbate by transition metals. Stich HF; Wei L; Whiting RF Cancer Res; 1979 Oct; 39(10):4145-51. PubMed ID: 476651 [TBL] [Abstract][Full Text] [Related]
18. The in vitro anti-herpes simplex virus type-1 and type-2 activity of Long Dan Xie Gan Tan, a prescription of traditional Chinese medicine. Cheng HY; Huang HH; Yang CM; Lin LT; Lin CC Chemotherapy; 2008; 54(2):77-83. PubMed ID: 18332627 [TBL] [Abstract][Full Text] [Related]
19. Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. Sergerie Y; Boivin G; Gosselin D; Rivest S J Infect Dis; 2007 Mar; 195(6):817-25. PubMed ID: 17299711 [TBL] [Abstract][Full Text] [Related]
20. In vitro inactivation of herpes simplex virus by a biological response modifier, PSK. Monma Y; Kawana T; Shimizu F Antiviral Res; 1997 Aug; 35(3):131-8. PubMed ID: 9298752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]